Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Ben Hasty/MediaNews Group/Reading Eagle via Getty Images
The latest wave of coronavirus testing concerns has arrived, this time about new at-home tests that are hitting the market, the Wall Street Journal reports.
Between the lines: Experts are worried about the accuracy of the tests and about limitations on who can access them.
The big picture: The Food and Drug Administration has so far given emergency authorization to six at-home collection kits, which still must be sent to a lab.
- These tests, in theory, expand testing access to people who can't easily leave their homes and to those who would be at-risk in a doctor's office around other patients. They also add to the total number of available tests.
- They're appealing to employers who want to test their workers and universities that want to test faculty and students.
Yes, but: The tests aren't foolproof, and can produce varying rates of false negatives depending on where the sample is collected from.
- They are also dependent on lab capacity to process them.
- And for some people, the tests' price tag could be prohibitive if it isn't fully covered by insurance or if they're uninsured.
Go deeper: Many Americans live in places with no coronavirus test sites